SEC Form 4 · accession 0001628908-19-000011
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lydia Stone
Officer — Chief Accounting Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2,F3 | Mar 1, 2019 | A | 8,465 | $0.00 | A | 23,855 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Option (right to buy)F4 | $13.29 | Mar 1, 2019 | A | 16,164 | A | — | Mar 1, 2029 | Class A Common Stock | 16,164 | 16,164 | D |
Explanation of responses
- F1Represents restricted stock units granted to Ms. Stone pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- F2Securities vest at a rate of 25% annually beginning March 1, 2020.
- F3Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- F4Securities vest at a rate of 25% annually beginning March 1, 2020.